NCT02932904 Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers Status COMPLETED Phase PHASE4
NCT02919501 Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT02917941 A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02916771 Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02913508 Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease Status WITHDRAWN Phase PHASE2
NCT02906813 A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants Status COMPLETED Phase PHASE1
NCT02899884 Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain Status COMPLETED Phase N/A
NCT02897830 Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma Status TERMINATED Phase PHASE2
NCT02878083 Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT) Status TERMINATED Phase NA
NCT02873702 Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis Status TERMINATED Phase PHASE3
NCT02873689 Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients Status COMPLETED Phase PHASE3
NCT02861118 A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02845349 Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI) Status WITHDRAWN Phase PHASE3